CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice. - Wikidata - wikimedia - TriplyDB

CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice.

CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice.

http://www.wikidata.org/entity/Q36399304

about

The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus Regulatory dendritic cells for immunotherapy in immunologic diseases Dendritic cell subsets in type 1 diabetes: friend or foe?IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes.The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes.Oxidative stress: Biomarkers and novel therapeutic pathways.New strategies for Alzheimer's disease and cognitive impairment.Diabetes mellitus: channeling care through cellular discovery The FOX transcription factors regulate vascular pathology, diabetes and Tregs The "O" class: crafting clinical care with FoxO transcription factors.Molecular control of steady-state dendritic cell maturation and immune homeostasis.Dendritic cell-regulatory T-cell interactions control self-directed immunity.Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHD Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer Highly specialized role of Forkhead box O transcription factors in the immune system.DC expressing transgene Foxp3 are regulatory APC.Novel avenues of drug discovery and biomarkers for diabetes mellitus.Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone.Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.Distinct tryptophan catabolism and Th17/Treg balance in HIV progressors and elite controllers.Streptococcus pneumoniae invades erythrocytes and utilizes them to evade human innate immunity.Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.Altered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases.Block and tackle: CTLA4Ig takes on lupus.Infectious tolerance and the long-term acceptance of transplanted tissue.A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses.Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus.Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege Immune regulation by Foxo transcription factors."Sly as a FOXO": new paths with Forkhead signaling in the brain OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins Clever cancer strategies with FoxO transcription factors.Foxo in the immune system.A "FOXO" in sight: targeting Foxo proteins from conception to cancer.FoxO proteins: cunning concepts and considerations for the cardiovascular system.Expression of diabetes-associated genes by dendritic cells and CD4 T cells drives the loss of tolerance in nonobese diabetic mice Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy.A fork in the path: Developing therapeutic inroads with FoxO proteins.

P2860

Q26785900-12858BB3-248B-473B-8768-5E0B5CE7CA6E Q26800615-BC97DF73-CFA6-4303-840B-8F396327C514 Q26866216-6E46AE98-4E97-4B42-82A0-B719D6094A6E Q26866500-76C867AF-FABA-4F2B-B779-AF25AA681830 Q33382323-BAAD0FF1-0F14-46DD-8D29-2373E6527F44 Q33559343-94EBBC24-7F10-40A7-A840-D7076D393922 Q33682262-D78A40FA-10FE-46BA-AD9A-9FF64B3CB113 Q33717008-AD67551B-C5C7-415A-A012-8039D982B3B2 Q33749358-9D8133E4-E9B4-47C2-92CC-9FA15DE5FC04 Q33763033-B4781509-1EC9-4176-B193-B1A063C579BB Q33824809-F7243102-1391-4CBD-A160-EC4682E43C25 Q33882051-7681233C-599E-4BEA-8358-F01D2544F6DC Q34004810-312EF2C0-6C50-49B9-8804-EB89E362AE8E Q34209366-46FD4CB6-03B9-4CB7-A26D-6AFA45E68CE5 Q34323684-C4963345-432A-47FE-BBE3-B74BFCA18E72 Q34414152-11A7DF43-1025-430A-84D8-45C6BA38324C Q34492548-5E777F62-8934-4407-B22F-F44CEC9E4D5F Q34503547-ACF128FC-FACB-43C8-9DF1-A6B110FEB6EC Q34552287-386DCCC0-65C9-4450-897A-87671447F917 Q34612686-071FC33C-E4A4-42E1-8A6A-7D7EED408837 Q34655953-FD267F0F-9CB7-454D-8ADA-E8BDADE1C679 Q35023537-1DF25B55-4536-4F0D-8C9F-50E1B17EFE0D Q35032403-A33D0CA3-EB11-4748-B0BF-36BC06DB7B88 Q35261125-5C1053BD-028C-49AF-B52D-06E56F1895D4 Q35952614-94B97B1B-E350-4B4C-8A6C-85A80145E071 Q36088049-813C06FE-29C9-41F7-83C9-704893C0EE7A Q36563558-DA00CE73-16C4-4099-A2D3-3FFF1C2FA8A8 Q36567669-740F4D72-C6CF-4147-8383-3896B615125B Q36727444-8A7887D0-A81A-45D2-A5AD-AE7D9781C3B1 Q36899012-73AE4DF2-F53C-419F-A38B-6766BB94C6B8 Q36922997-6721798D-615A-446B-9585-3FF33460AFC6 Q36944469-7B724FB8-F7F4-4CDE-BC28-135036DB9912 Q36947037-5ED2B89A-7DC0-4B6B-9457-C3432638AFB8 Q37071395-BDAAD177-A723-4937-9738-1C07FE96F4BA Q37129806-7153A5AE-13BE-4FA3-8364-7F38D7436A3C Q37153195-B9A606CE-EC16-44CD-913A-8AC2A0AAE3C6 Q37195595-9C7D34CA-E801-4911-819E-BD231B592DD0 Q37323483-4242B3DC-D98A-427D-ADBD-450D2BE23F37 Q37352554-AF0E8BFC-9D26-4BE6-ADF3-E2BAC9192DDC Q37390262-6C798A99-462E-4A64-91EB-A6439EEA8FA5

P2860

CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice.

http://www.wikidata.org/entity/Q36399304

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

CTLA-4-Ig activates forkhead t ...... ess in nonobese diabetic mice.

@ast

CTLA-4-Ig activates forkhead t ...... ess in nonobese diabetic mice.

@en

type

label

CTLA-4-Ig activates forkhead t ...... ess in nonobese diabetic mice.

@ast

CTLA-4-Ig activates forkhead t ...... ess in nonobese diabetic mice.

@en

prefLabel

CTLA-4-Ig activates forkhead t ...... ess in nonobese diabetic mice.

@ast

CTLA-4-Ig activates forkhead t ...... ess in nonobese diabetic mice.

@en

P1433

Q36399304-75F8115E-435E-4026-B613-5107B07BAFC1

P1476

Q36399304-84E65CFC-1215-4CA0-A3C5-E239BC9D03B7

P2093

Q36399304-1FA41E3E-9CC1-4878-86FC-01A7E3F89D92

Q36399304-55E80596-26CE-479A-870E-C7FAF7110150

Q36399304-588553E6-350C-4F24-A43A-4C780E219F28

Q36399304-867F4198-CFF1-48A9-8585-2AA7FAB6C054

Q36399304-960BFFA6-E3AC-4380-AA81-12561B5F2465

Q36399304-ADBCC218-9A46-4476-AA29-044EEC9A4683

Q36399304-AE17AC04-6A57-4035-AD32-D9CD8E37633C

Q36399304-BD8C28A4-8994-44E0-B79E-D2B613BE4717

Q36399304-CB4D4319-7CF2-473F-A0EE-80EFDE6D92B6

P2860

Q36399304-02DC0BD1-4B8B-42AB-BB65-7867FE1BE018

Q36399304-052D2D74-48B1-4230-831B-463CA3BC6507

Q36399304-0592223C-97EB-4A79-9328-63B98409ECC9

Q36399304-066E5A13-09B1-4492-A12A-63847BB75A97

Q36399304-09726B41-768F-46A4-8334-064C3E8631F3

Q36399304-09F65B6A-557E-459F-84A5-7AF748634F4D

Q36399304-0CDED59D-E2E2-4266-BE0B-16ACEFFC3B07

Q36399304-0F3FB798-DE2B-424D-A27B-095282BA20D9

Q36399304-1586180F-7B42-4945-8DCA-BE6C9BD84F26

Q36399304-181F8F1D-90AD-4A40-B8BE-EFD44D95BADA

P304

Q36399304-AA2ACED4-64EE-4417-9E29-F66A8C3157C9

P31

Q36399304-2BCB1406-8CCA-4E5D-A997-89BC608038AA

P356

Q36399304-898ADED9-B770-40F8-80BF-194AEEC4A5E2

P407

Q36399304-8642503D-F942-4B8E-BF14-3E0D7BEAD482

P433

Q36399304-6C85B48B-5513-4021-84A3-80188F7D06A7

P478

Q36399304-C773FBE1-C4A8-4272-B6F3-C34AF1CE3E23

P577

Q36399304-2DED739C-0E2B-429B-BFE9-C423F78B8FD4

P5875

Q36399304-D28DC7D8-C2A4-45DA-9ECD-1D37D58B74A4

P698

Q36399304-B008C643-FAB4-44DF-BBFD-947D83AEC699

P932

Q36399304-3164B16A-8FC5-44EA-8CA7-4B0DBFF57D50

P356

P1433

Journal of Experimental Medicine

P1476

CTLA-4-Ig activates forkhead t ...... ess in nonobese diabetic mice.

@en

P2093

Carmine Vacca

http://www.w3.org/2001/XMLSchema#string

Ciriana Orabona

http://www.w3.org/2001/XMLSchema#string

David V Serreze

http://www.w3.org/2001/XMLSchema#string

Francesca Fallarino

http://www.w3.org/2001/XMLSchema#string

Maria C Fioretti

http://www.w3.org/2001/XMLSchema#string

Maria L Belladonna

http://www.w3.org/2001/XMLSchema#string

Paolo Puccetti

http://www.w3.org/2001/XMLSchema#string

Roberta Bianchi

http://www.w3.org/2001/XMLSchema#string

Ursula Grohmann

http://www.w3.org/2001/XMLSchema#string

P2860

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

Prevention of allogeneic fetal rejection by tryptophan catabolism

Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and Staurosporine

Tolerance, DCs and tryptophan: much ado about IDO

Protein kinase B-alpha inhibits human pyruvate dehydrogenase kinase-4 gene induction by dexamethasone through inactivation of FOXO transcription factors

Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice

Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells

A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)

Cell cycle and death control: long live Forkheads

Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress

P304

1051-1062

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20040942

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

200

http://www.w3.org/2001/XMLSchema#string

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8225145

http://www.w3.org/2001/XMLSchema#string

P698

15492127

http://www.w3.org/2001/XMLSchema#string

P932

2211844

http://www.w3.org/2001/XMLSchema#string